Hmn-384 -

(Note: As HMN-384 is a hypothetical compound generated for this paper, references to specific clinical trial data or previous patents are simulated based on the current literature regarding CDK11 and kinase inhibitor development.)

It is highly useful for high-throughput screening of BK channel (large-conductance calcium-activated potassium channel) activators. Methodology: HMN-384